DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Balar AV. et al.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Lancet 2017;
389: 67-76
We do not assume any responsibility for the contents of the web pages of other providers.